S,S,S)-(+)-(3,5-Dioxa-4-phosphacyclohepta[2.1-A:¾-a]dinaphthalen-4-yl)bis(1-phénylethyl)amine, 97 %

Non disponible en dehors du Royaume-Uni et de l'Irlande

Application

The product may be used as a ligand in:Iridium-catalyzed allylic etherification of acyclic, achiral allylic carbonates with potassium silanolates to form chiral allylic alcohols.Palladium-catalyzed asymmetric allylic cyclisation of N-tosyl and N-benzyl carbonates to form the corresponding pyrrolidine and piperidine derivatives, respectively.Intramolecular iridium-catalyzed allylic cyclizationof (E)-allylic methyl carbonates to form 2,5-trans/cis pyrrolidine derivatives.

Chiral phosphoramidite ligand used in a highly enantioselective copper-catalyzed conjugate addition of diakylzincs to a variety of Michael acceptors. Also used in a palladium-catalyzed diethylzinc mediated umpolung allylation.

DSM MonoPhos Family of Highly Efficient Privileged Ligands

Features and Benefits

Advantages of the MonoPhos^® ligands:Superior enantiocontrol in numerous transformationsHigh activities at low catalyst loadingsHydrogenations under low-pressure conditions

Legal Information

MonoPhos is a registered trademark of DSM IP Assets B.V.

Sold under license from DSM for research purposes only.

Packaging

100, 500 mg in glass insert

2 g in glass bottle